PubMed HealthSearch

Biomedical subjects

J P Seltzer

Publications and source records attributed to J P Seltzer.

6 recordsLinked to original sources

Five-year performance of the Medtronic 6971 polyurethane endocardial electrode.

There is a considerable debate over the long-term performance of polyurethane electrodes. Observation to date has demonstrated surface cracking and some clinical failures in patients. Since 1978 we have implanted about 82 6971 Unipolar Medtronic electrodes in the ventricle. In 33 patients, lead integrity was assessed by chronic thresholds determined by decreasing pulse width and pulse amplitude. Sensing functions were assessed by electrocardiographic rhythm analysis. At a follow-up between 7 and 67 months, chronic thresholds at 2.50 volts were 0.08 +/- 0.04 milliseconds in 26 patients with Medtronic Pulse generators (Models 8423, 5985, and 7000). In two patients with similar units, no loss of capture was seen even at 0.05 milliseconds. Three patients, one with Cordis Unit (233F) showed loss of capture at 0.20 milliseconds at 2.00 MA, the other with a Pacesetter unit (255-6) showed loss of capture at 0.20 milliseconds, at 2.50 volts. One patient with Intermedics unit (283) lost capture at 0.07 milliseconds at 2.70 volts. Insulation breaks seen in two patients were demonstrated by pectoral stimulation and pacemaker oversensing. In addition, 24-hour long-term electrocardiographic monitoring was performed in 22 patients between 23 to 70 months. Appropriate pacemaker function was seen except in one patient who demonstrated oversensing. Interruption in insulation was demonstrated at the ligature site at exploration. Thus, in this series of patients who were paced in the ventricle by the 6971 Medtronic electrode, only two patients have demonstrated insulation failure. The incidence of insulation break in this polyurethane unipolar electrode is uncommon and occurs at further stress points.

Electrodes, Implanted

Patient-initiated autonomous pacemaker tachycardia.

Multiparameter programmable DDD pacemakers are said to have an uncountable number of possible parameter combinations. It is probable that a number of these combinations, particularly when triggered by one or more critically timed native events, will result in bizarre and unanticipated rhythms sustained entirely within the timing circuit of the pulse generator. We report the occurrence and analysis of one such rhythm termed a sustained autonomous pacemaker tachycardia. In this rhythm, both atrial and ventricular outputs occur at the maximum tracking rate of the pacemaker with an apparently shortened AV interval. Once initiated, the ability to sustain the tachycardia requires that the maximum tracking rate interval exceed the atrial escape interval. It will then continue until the pulse generator is programmed to parameters that alter this critical timing or a properly timed ventricular sensed event occurs. It is anticipated that this will be only one of many similar rhythms encountered in patients treated with complex devices from all the manufacturers. In the future, once such a rhythm is noted and its mechanism identified, modifications of the basic circuit design will allow these parameters to be used without danger to the patient and without having to limit the options of the device.

Bradycardia

Assessment of atrial capture in committed atrioventricular sequential (DVI) pacing systems.

Two patients with committed dual unipolar AV sequential pacing systems are presented in whom atrial capture was unable to be demonstrated on the surface electrocardiogram. The bedside examination is proposed as a means of identifying the presence or absence of atrial capture with subsequent confirmation by M-mode echocardiographs and jugular venous pulse tracings. Mode, rate, and output programmability may aid in the evaluation of these pacing systems. Intentional reduction of the ventricular output to subthreshold levels in pacemakers capable of this degree of programmability will permit the rapid bedside confirmation of atrial capture without the need for expensive and time-consuming noninvasive tests.

Aged